These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The pharmacokinetics and efficacy of different estrogens are not equivalent. Ansbacher R Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women. Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623 [TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of conjugated equine estrogens in healthy, postmenopausal women. Mayer P; Tse S; Sendi M; Bourg D; Morrison D J Reprod Med; 2008 Feb; 53(2):97-101. PubMed ID: 18357800 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic deficiency in the Women's Health Initiative Study. Stanczyk FZ; Chaikittisilpa S; Roy S J Reprod Med; 2003 Jun; 48(6):485-6. PubMed ID: 12856527 [No Abstract] [Full Text] [Related]
11. [Clinical effectiveness of a new matrix plaster: an overview]. Schindler AE; Schindler EM Zentralbl Gynakol; 1995; 117(10):508-9. PubMed ID: 7491832 [No Abstract] [Full Text] [Related]
12. Conjugated estrogens (Premarin) vaginal cream. Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162 [TBL] [Abstract][Full Text] [Related]
13. A prospective 1-year study of estrogen and progestin in postmenopausal women: effects on the endometrium. Gelfand MM; Ferenczy A Obstet Gynecol; 1989 Sep; 74(3 Pt 1):398-402. PubMed ID: 2548135 [TBL] [Abstract][Full Text] [Related]
14. Double-blind, cross-over study comparing chlordiazepoxide, conjugated estrogens, combined chlordiazepoxide and conjugated estrogens, and placebo in treatment of the menopause. Sheffery JB; Wilson TA; Walsh JC Med Ann Dist Columbia; 1969 Aug; 38(8):433-6. PubMed ID: 4307908 [No Abstract] [Full Text] [Related]
15. Status of generic substitution: problematic drug classes reviewed. Ross MB Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356 [TBL] [Abstract][Full Text] [Related]
16. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium. Handa VL; Bachus KE; Johnston WW; Robboy SJ; Hammond CB Obstet Gynecol; 1994 Aug; 84(2):215-8. PubMed ID: 8041532 [TBL] [Abstract][Full Text] [Related]
17. [Observations on therapy with natural conjugated estrogens in pre- and post-menopausal subjects]. Solaro F; Rovere F; Dinale M; Traverso E G Gerontol; 1969 Jul; 17(7):709-20. PubMed ID: 4314583 [No Abstract] [Full Text] [Related]
18. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women. Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229 [TBL] [Abstract][Full Text] [Related]
19. [Conjugated estrogens in the climacteric]. Warnecke G Med Welt; 1966 Jun; 26():1410-3. PubMed ID: 4289950 [No Abstract] [Full Text] [Related]
20. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]